UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000023583
Receipt No. R000027160
Official scientific title of the study The analysis of the molecules those contribute to renal damage in chronic kidney disease.
Date of disclosure of the study information 2016/08/10
Last modified on 2016/08/10 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The analysis of the molecules those contribute to renal damage in chronic kidney disease.
Title of the study (Brief title) The molecules those contribute to renal damage.
Region
Japan

Condition
Condition Chronic kidney disease patients
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 To investigate moleclues those contribute to renal damage.
Basic objectives2 Others
Basic objectives -Others To detect moleclues those contribute to renal damage in chronic kidney disease patients
Trial characteristics_1
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Analyze moleclues that contribute to renal damage in chronic kidney disease patinets.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)CKD patients.
2)The patients who undergo hemodialysis ot peritoneal dialysis.
Key exclusion criteria 1)The patinets who cannot understand informed consent.
Target sample size 500

Research contact person
Name of lead principal investigator Yoshiyuki Morishita
Organization Saitama Medical Center, Jichi Medical University
Division name Division of Nephrology, Department of Integrated Medicine
Address 1-847, Amanuma, Omiya-ku, Saitama-city, Saitama, 330-8503, Japan
TEL 0486472111
Email ymori@jichi.ac.jp

Public contact
Name of contact person Yoshiyuki Morishita
Organization Saitama Medical Center, Jichi Medical University
Division name Division of Nephrology, Department of Integrated Medicine
Address 1-847, Amanuma, Omiya-ku, Saitama-city, Saitama, 330-8503, Japan
TEL 0486472111
Homepage URL
Email ymori@jichi.ac.jp

Sponsor
Institute Jichi Medical University
Institute
Department

Funding Source
Organization Jichi Medical University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 08 Month 10 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2015 Year 12 Month 22 Day
Anticipated trial start date
2015 Year 12 Month 22 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information The analysis of the association between the molecules and renal damage.

Management information
Registered date
2016 Year 08 Month 10 Day
Last modified on
2016 Year 08 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027160